DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
People / Steve Tregay
Steve Tregay
Roles
1 current, 0 past
- Mission Biocapital Managing General Partner? to present · “said Steve Tregay, Managing General Partner at Mission BioCapital.”
Investments attributed to this person
1
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| ImmunOs Therapeutics AG | Funding round · $11.0M | Mission Biocapital | confirmed | Sep 17, 2024 | Fact globenewswire.com |
Board seats and vehicles
1 boards, 0 vehicles
- Alessa Therapeutics, Inc. Director May 1, 2025 Fact
Timeline
0
No dated event.